Skip to main content
SpringerLink
Log in

Factors Contributing to the Development of Atherosclerosis

  • Chapter
  • First Online:
Atherosclerosis: Clinical Perspectives Through Imaging

  • 1415 Accesses

Abstract

Beginning with the Framingham Heart Study, there have been numerous, large epidemiological studies across the world identifying many conventional and novel risk factors for the development and progression of atherosclerosis. Certain of these well-established risk factors are modifiable, to include hypertension, diabetes, and cigarette smoking, whereas others are non-modifiable, such as age, male gender, and family history of premature heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potential modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937.

    Article  PubMed  Google Scholar 

  2. Keil U, Kuulasmaa K, for the WHO MONICA Project. WHO MONICA Project: risk factors. Int J Epidemiol. 1989;18 Suppl 1:S46–55.

    PubMed  CAS  Google Scholar 

  3. Stamler J, Wentworth D, Neaton JD, MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823–8.

    Article  PubMed  CAS  Google Scholar 

  4. Stemmermann GN, Chyou PH, Kagan A, Nomura AMY, Yano K. Serum cholesterol and mortality among Japanese-American men: the Honolulu (Hawaii) Heart Program. Arch Intern Med. 1991;151:969–72.

    Article  PubMed  CAS  Google Scholar 

  5. Margolis JR, Gillum RF, Feinleib M, Brasch RC, Fabsitz RR. Community surveillance for coronary heart disease: The Framingham Cardiovascular Disease survey. Am J Cardiol. 1976;37:61.

    Article  PubMed  CAS  Google Scholar 

  6. CDC. Annual smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 2000–2004. MMWR Morb Mortal Wkly Rep. 2008;57(45):1226–8.

    Google Scholar 

  7. Howard G, Wagenknecht LE, Burke GL, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279(2):119–24.

    Article  PubMed  CAS  Google Scholar 

  8. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease. JACC. 2004;43:1731–7.

    PubMed  CAS  Google Scholar 

  9. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290(1):86–97.

    Article  PubMed  Google Scholar 

  10. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet. 2002;360: 1903–13.

    Article  PubMed  Google Scholar 

  11. Law M, Wald N, Morris J, Jordan R. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427.

    Article  PubMed  CAS  Google Scholar 

  12. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560.

    Article  PubMed  CAS  Google Scholar 

  13. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–209.

    Article  PubMed  Google Scholar 

  14. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care. 1979;2:120–6.

    Article  PubMed  CAS  Google Scholar 

  15. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.

    Article  PubMed  CAS  Google Scholar 

  16. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–8.

    Article  PubMed  Google Scholar 

  17. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation. 2002;106:3143.

    Google Scholar 

  18. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.

    Article  PubMed  CAS  Google Scholar 

  19. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto Jr AM, AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA. 1998;279:1615.

    Article  PubMed  CAS  Google Scholar 

  20. Cholesterol Treatment Trialists’ Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–78.

    Article  Google Scholar 

  21. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs Jr DR, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8–15.

    Article  PubMed  CAS  Google Scholar 

  22. Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation. 2004;110(23):3512.

    Article  PubMed  CAS  Google Scholar 

  23. NIH stops clinical trial on combination cholesterol treatment. http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2792. Accessed 18 Jun 2011.

  24. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81(4A):7B–12.

    Article  PubMed  CAS  Google Scholar 

  25. Lakka H, Laaksonen D, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16.

    Article  PubMed  Google Scholar 

  26. Lloyd-Jones DM, Nam BH, D’Agostino Sr RB, Levy D, Murabito JM, Wang TJ, Wilson PW, O’Donnell CJ. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291:2204–11.

    Article  PubMed  CAS  Google Scholar 

  27. Nasir K, Budoff MJ, Wong ND. Family history of premature coronary heart disease and coronary artery calcification. Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;116(6):619–26.

    Article  PubMed  Google Scholar 

  28. Franco OH, de Laet C, Peeters A, Jonker J, Mackenbach J, Nusselder W. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med. 2005;165:2355–60.

    Article  PubMed  Google Scholar 

  29. Rodriguez BL, Curb JD, Burchfiel CM, et al. Physical activity and 23-year incidence of coronary heart disease morbidity and mortality among middle-aged men: The Honolulu Heart Program. Circulation. 1994;89:2540–4.

    Article  PubMed  CAS  Google Scholar 

  30. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendations for adults form the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1081–93.

    Article  PubMed  Google Scholar 

  31. Summary E. Standards of medical care in diabetes – 2008. Diabetes Care. 2008;31:S5–11.

    Article  Google Scholar 

  32. Grundy SM, Pasternak R, Greenland P, Smith Jr S, Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations assessment of cardiovascular risk. J Am Coll Cardiol. 1999;34:1348–59.

    Article  PubMed  CAS  Google Scholar 

  33. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105:310–5.

    Article  PubMed  Google Scholar 

  34. Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. AJC. 2002;144:95–100.

    Google Scholar 

  35. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611–9.

    Article  PubMed  CAS  Google Scholar 

  36. McClelland RL, Nasir K, Budoff M. Arterial age as a function of coronary artery calcium (from the Multi-Ethnic Study of Atherosclerosis MESA). Am J Cardiol. 2009;103(1):59–63.

    Article  PubMed  CAS  Google Scholar 

  37. Munir JA, Wu H, Bauer H, et al. Impact of coronary calcium on arterial age and coronary heart disease risk estimation using the MESA arterial age calculator. Atherosclerosis. 2010;211:467–70.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Tripler Army Medical Center, 1 Jarrett White Rd, Honolulu, HI, 96859, USA

    Jamalah A. Munir M.D.

Authors
  1. Jamalah A. Munir M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jamalah A. Munir M.D. .

Editor information

Editors and Affiliations

  1. MedStar Washington Hospital Center, Irving Street 110, Washington, 20010, District of Columbia, USA

    Allen J. Taylor

  2. Walter Reed Army Medical Center, Georgia Avenue, Washington, 20307, Washington, USA

    Todd C. Villines

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Munir, J.A. (2013). Factors Contributing to the Development of Atherosclerosis. In: Taylor, A., Villines, T. (eds) Atherosclerosis: Clinical Perspectives Through Imaging. Springer, London. https://doi.org/10.1007/978-1-4471-4288-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4288-1_2

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4287-4

  • Online ISBN: 978-1-4471-4288-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation